Request Demo
Pharmaceutical Insights
Navigate pharmaceutical trends with our insights on targets, institutional pipelines, clinical advances, and new drugs.
Recent blog posts
9 min read
RPT1G in Acute Myeloid Leukemia: NCT07107126 Clinical Landscape Report 2026
15 October 2026
NCT07107126 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
GV20-0251 in Hepatocellular Carcinoma: NCT07106827 Clinical Landscape Report 2026
15 October 2026
NCT07106827 clinical landscape for Hepatocellular Carcinoma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
CD180 CART(Hematology Hospital of Chinese Academy of Medical Sciences) in Acute Myeloid Leukemia: NCT07106749 Clinical Landscape Report 2026
15 October 2026
NCT07106749 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anti-BCMA CAR-T(Institute of Hematology & Blood Diseases Hospital) in Multiple Myeloma: NCT07106736 Clinical Landscape Report 2026
15 October 2026
NCT07106736 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anti-BCMA CAR-T(Institute of Hematology & Blood Diseases Hospital) in Multiple Myeloma: NCT07106710 Clinical Landscape Report 2026
15 October 2026
NCT07106710 clinical landscape for Multiple Myeloma: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Anti-BCMA CAR-T(Institute of Hematology & Blood Diseases Hospital) in Plasma Cell Leukemia: NCT07106684 Clinical Landscape Report 2026
15 October 2026
NCT07106684 clinical landscape for Plasma Cell Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
UB-VV410 in Lupus Nephritis: NCT07109986 Clinical Landscape Report 2026
15 October 2026
NCT07109986 clinical landscape for Lupus Nephritis: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Stapokibart in Dermatitis, Atopic: NCT07106372 Clinical Landscape Report 2026
15 October 2026
NCT07106372 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Siltuximab in Neurotoxicity Syndromes: NCT07106671 Clinical Landscape Report 2026
15 October 2026
NCT07106671 clinical landscape for Neurotoxicity Syndromes: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
BFB-759 in Dermatitis, Atopic: NCT07105488 Clinical Landscape Report 2026
15 October 2026
NCT07105488 clinical landscape for Dermatitis, Atopic: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
uCD7 CART(Hematology Hospital of Chinese Academy of Medical Sciences) in Acute Myeloid Leukemia: NCT07109518 Clinical Landscape Report 2026
15 October 2026
NCT07109518 clinical landscape for Acute Myeloid Leukemia: endpoints, sponsor, phase, geography, readouts, asset context and development white space.
9 min read
Fulvestrant in Ovarian Cancer: NCT07109726 Clinical Landscape Report 2026
15 October 2026
NCT07109726 clinical landscape for Ovarian Cancer: endpoints, sponsor, phase, geography, readouts, asset context and development white space.